Authors:
AN ZL
WANG XE
WILLMOTT N
CHANDER SK
TICKLE S
DOCHERTY AJP
MOUNTAIN A
MILLICAN AT
MORPHY R
PORTER JR
EPEMOLU RO
KUBOTA T
MOOSSA AR
HOFFMAN RM
Citation: Zl. An et al., CONVERSION OF HIGHLY MALIGNANT COLON-CANCER FROM AN AGGRESSIVE TO A CONTROLLED DISEASE BY ORAL-ADMINISTRATION OF A METALLOPROTEINASE INHIBITOR, Clinical & experimental metastasis, 15(2), 1997, pp. 184-195
Authors:
AFZAL S
LALANI EN
FOULKES WD
BOYCE B
TICKLE S
CARDILLO MR
BAKER T
PIGNATELLI M
STAMP GWH
Citation: S. Afzal et al., MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 EXPRESSION AND SYNTHETIC MATRIX METALLOPROTEINASE-2 INHIBITOR BINDING IN OVARIAN CARCINOMAS AND TUMOR-CELL LINES, Laboratory investigation, 74(2), 1996, pp. 406-421
Authors:
DOCHERTY AJP
BAKER TS
BEELEY NRA
BIRCH ML
BOYCE BA
COCKETT MI
CRABBE T
EATON D
HART IR
HYNDS P
LEONARD J
MAHADEVAN V
MASON B
MILLICAN TA
MORPHY JR
MOUNTAIN A
MURPHY G
OCONNELL J
PORTER J
TICKLE S
WARD RV
WILLENBROCK F
WILLMOTT N
Citation: Ajp. Docherty et al., GELATINASE-A AND THE METASTATIC PHENOTYPE - PROSPECTS FOR TREATING INVASIVE CANCERS WITH SELECTIVE GELATINASE INHIBITORS, Cell biology international, 19(3), 1995, pp. 245-246
Authors:
BAKER T
TICKLE S
WASAN H
DOCHERTY A
ISENBERG D
WAXMAN J
Citation: T. Baker et al., SERUM METALLOPROTEINASES AND THEIR INHIBITORS - MARKERS FOR MALIGNANTPOTENTIAL, British Journal of Cancer, 70(3), 1994, pp. 506-512
Authors:
CRABBE T
ZUCKER S
COCKETT MI
WILLENBROCK F
TICKLE S
OCONNELL JP
SCOTHERN JM
MURPHY G
DOCHERTY AJP
Citation: T. Crabbe et al., MUTATION OF THE ACTIVE-SITE GLUTAMIC-ACID OF HUMAN GELATINASE-A - EFFECTS ON LATENCY, CATALYSIS, AND THE BINDING OF TISSUE INHIBITOR OF METALLOPROTEINASES-1, Biochemistry, 33(21), 1994, pp. 6684-6690